[HTML][HTML] Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
WJ Li, P Archontakis-Barakakis… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Most of the randomized clinical trials that led to the wide use of non-vitamin
K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …
K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …
[PDF][PDF] WJC
WJ Li, P Archontakis-Barakakis, L Palaiodimos… - …, 2021 - pdfs.semanticscholar.org
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular
atrial fibrillation: An updat Page 1 WJC https://www.wjgnet.com 82 April 26, 2021 Volume 13 …
atrial fibrillation: An updat Page 1 WJC https://www.wjgnet.com 82 April 26, 2021 Volume 13 …
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
WJ Li, P Archontakis-Barakakis… - World journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Most of the randomized clinical trials that led to the wide use of non-vitamin K
antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …
antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis.
WJ Li, P Archontakis-Barakakis… - World Journal of …, 2021 - europepmc.org
Background Most of the randomized clinical trials that led to the wide use of non-vitamin K
antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …
antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …
Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis.
WJ Li, P Archontakis-Barakakis… - World Journal of …, 2021 - europepmc.org
Background Most of the randomized clinical trials that led to the wide use of non-vitamin K
antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …
antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …